If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,630.00    -10.00 (-0.18%)
Bid:
5,630.00
Ask:
5,660.00
Spread: 30.00 (0.533%)
Market Cap: £3.01b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Fourth Quarter Trading Statement

7 Apr 2014 07:00

RNS Number : 1498E
Cranswick PLC
07 April 2014
 



7 April 2014

 

Cranswick plc

("Cranswick" or "the Group" or "the Company")

 

Trading statement for the year ended 31 March 2014

 

Cranswick plc issues the following update on trading for the year ended 31 March 2014. Cranswick expects to announce its full year results on 19 May 2014.

 

Current trading

 

Underlying sales increased by 12 per cent in the year ended 31 March 2014.

 

Total sales for the year were 13 per cent higher after taking into account the contribution from acquisitions. Strong growth was seen across most product categories, particularly fresh pork, bacon and cooked meats. Pastry sales also continue to grow strongly following the successful launch of several new product ranges during the year. Export sales were well ahead of the levels reported in the previous financial year, reflecting robust demand for pork products in Far Eastern markets.

 

The Group invested in excess of £20 million in its infrastructure during the year ended 31 March 2014, allowing it to further improve operational efficiencies and to launch new product ranges. The Group's new gourmet pastry facility at Malton, North Yorkshire, was successfully commissioned earlier in the financial year, albeit with higher than anticipated start-up costs and work is ongoing on the extension to the Milton Keynes cooked meats facility which will add substantial capacity and deliver further efficiency gains.

 

As previously reported, the record input prices seen during the year impacted operating margins#. Despite some recovery as the year progressed, operating margins# will, as expected, be slightly below those achieved in the previous financial year.

 

Financial position

 

Notwithstanding the significant capital investment programme and the acquisition of the pig breeding and rearing activities earlier in the year, strong cash generation from operating activities through the final quarter will result in year-end net debt being substantially lower than at the end of quarter three and below the level reported at the last financial year end.

 

The Group recently extended the term and increased the size of its banking facility, leaving the business in a sound financial position, with committed, unsecured facilities of £120 million which provide generous headroom through to July 2018.

 

Outlook

 

With experienced management at all levels of the Group, a strong range of products, a well invested asset base and a robust financial position, the Board remains confident in the continued long term success and development of the business.

 

 

 

Enquiries:

Paul Quade 07947 186694

CityRoad Communications 020 7248 8010

 

 

 

 Notes:

1. Cranswick's activities are focused within the UK and include the breeding and rearing of premium British pigs, together with the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2013 showed sales of £875m and profit before tax of £47.4m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

 

# excluding net IAS 41 valuation movement on biological assets in the current financial year and non-recurring items in both the current and prior financial years

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQZLFBZZFZBBQ
Date   Source Headline
20th May 202112:06 pmRNSDirector/PDMR Shareholding
20th May 202112:03 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company
3rd Nov 20205:15 pmRNSTotal Voting Rights
27th Oct 20202:55 pmRNSHolding(s) in Company
27th Oct 20202:51 pmRNSHolding(s) in Company
26th Oct 202011:51 amRNSHolding(s) in Company
1st Oct 20201:54 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20201:49 pmRNSTotal Voting Rights
25th Sep 20202:34 pmRNSHolding(s) in Company
2nd Sep 20202:01 pmRNSAdditional Listing
1st Sep 202011:45 amRNSDirector/PDMR Shareholding
1st Sep 202011:18 amRNSTotal Voting Rights
17th Aug 20202:57 pmRNSPoll Result for 2020 Annual General Meeting
17th Aug 20207:00 amRNSFirst quarter trading statement
11th Aug 20207:00 amRNSAnnual General Meeting update
3rd Aug 20202:30 pmRNSTotal Voting Rights
31st Jul 202012:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.